Transfer of Aneuploid or Mosaic Embryos Following Preimplantation Genetic Testing
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 55
Healthy Volunteers: t
View:
• Available aneuploid or mosaic embryos
• No other acceptable embryos available
• Willing to travel to Stanford for treatment
• English language fluency
Locations
United States
California
Stanford Fertility and Reproductive Medicine Center
RECRUITING
Sunnyvale
Contact Information
Primary
Ronit Mazzoni, MS
rmazzoni@stanford.edu
408-688-9892
Backup
REI Research Coordinator
rei-research@lists.stanford.edu
408-688-9892
Time Frame
Start Date: 2019-04-11
Estimated Completion Date: 2039-04-01
Participants
Target number of participants: 300
Treatments
Experimental: Non-euploid Transfer
Patients desiring pregnancy who have no acceptable euploid embryos available for transfer who chose to undergo embryo transfer of a non-euploid embryo (either aneuploid or mosaic).
Active_comparator: Euploid Transfer
Patients desiring pregnancy who are undergoing euploid embryo transfer
Related Therapeutic Areas
Sponsors
Leads: Stanford University